Frontlight ResearchEarly access
ANCA-associated vasculitis trials in Canada
3 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Calgary, Hamilton, Toronto
- Age
- 6 years and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - Phase 3Taking peopleA Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
- Where
- Toronto
- Age
- 6 years to 17 years
- People
- 14 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06512883 · EU 2023-508533-14-00 - Phase 3Taking peopleSafe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
- Where
- Hamilton, Ottawa
- Age
- 18 years and over
- People
- 36
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT06983821